Wikipedia:Version 1.0 Editorial Team/Pharmacology articles by quality log

This is a log of operations by a bot. The contents of this page are unlikely to need human editing. In particular, links should not be disambiguated as this is a historical record.

June 24, 2024[edit]

Reassessed[edit]

• Androgen (medication) (talk) reassessed. Quality rating changed from Disambig-Class to Unassessed-Class. (rev · t) Importance rating changed from NA-Class to Unknown-Class. (rev · t)
• West of Scotland Coronary Prevention Study (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)

June 23, 2024[edit]

Reassessed[edit]

• Idropranolol (talk) reassessed. Quality rating changed from Stub-Class to Redirect-Class. (rev · t) Importance rating changed from Unknown-Class to NA-Class. (rev · t)
• Party and play/Archive 1 (talk) reassessed. Quality rating changed from Start-Class to NA-Class. (rev · t)

Assessed[edit]

• AF-353 (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)

June 22, 2024[edit]

Renamed[edit]

• 3D drug printing renamed to 3D printed medication.

Reassessed[edit]

• Crovalimab (talk) reassessed. Importance rating changed from Unknown-Class to Mid-Class. (rev · t)
• Tartaric acid (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)

Assessed[edit]

• 3D printed medication (talk) assessed. Quality assessed as NA-Class. (rev · t) Importance assessed as Low-Class. (rev · t)

June 21, 2024[edit]

Reassessed[edit]

• 3D drug printing (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
• 3D printed medicine (talk) reassessed. Quality rating changed from Start-Class to Redirect-Class. (rev · t)
• Sofpironium bromide (talk) reassessed. Importance rating changed from Low-Class to Mid-Class. (rev · t)

June 20, 2024[edit]

Renamed[edit]

• Pharmacists Council of Nigeria renamed to Pharmacy Council of Nigeria.

Reassessed[edit]

• Bifluranol (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Carboprost (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Demoxytocin (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Equilenin (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Navitoclax (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Nogalamycin (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Norsalsolinol (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Plinabulin (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Tacalcitol (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Tesamorelin (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Thymoquinone (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)

Assessed[edit]

• Pharmacy Council of Nigeria (talk) assessed. Quality assessed as NA-Class. (rev · t) Importance assessed as Low-Class. (rev · t)

June 19, 2024[edit]

Reassessed[edit]

• Dacomitinib (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Sulfanegen (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)

Assessed[edit]

• Draft:Somai Pharmaceuticals (talk) assessed. Importance assessed as NA-Class. (rev · t)

June 18, 2024[edit]

Reassessed[edit]

• Fosravuconazole (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Hydrogen peroxide–urea (talk) reassessed. Quality rating changed from Redirect-Class to C-Class. (rev · t)

Assessed[edit]

• Bex (compound analgesic) (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)